RIYADH: The Saudi Ministry of Investment has signed an initial agreement with UK research-based pharmaceutical and healthcare giant GlaxoSmithKline to uplift the pharmaceuticals sector in the Kingdom.

Both parties have agreed to localize the manufacturing of the firm’s prominent products, as well as transfer knowledge and technology.

Joint market research and studies with UK-based healthcare experts will also take place as part of the agreement.

The collaboration aims to transform the Kingdom into a regional hub for research in the medical self-care industry.

This will propel the advancement of the Saudi healthcare sector, falling in line with the Saudi Vision 2030 framework.


Copyright: Arab News © 2022 All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.